Author: Site Editor Publish Time: 2023-10-12 Origin: Site
Today is World Arthritis Day, a global initiative to raise awareness and support for people living with arthritis. Arthritis is a term that refers to more than 100 different conditions that affect the joints, causing pain, stiffness, inflammation, and damage. Some of the most common types of arthritis are osteoarthritis, rheumatoid arthritis, psoriatic arthritis, and gout.
There are some lab tests that can help doctors to identify and monitor arthritis. Biomarkers are substances that can be measured in the blood or joint fluid and serve as indicators of normal or abnormal processes in the body.
One of the most widely used biomarkers for arthritis is rheumatoid factor (RF), which is an antibody that is often found in the blood of people with rheumatoid arthritis.
Another biomarker that is more specific to rheumatoid arthritis is anti-cyclic citrullinated peptide (anti-CCP), which is an antibody that targets proteins that have been modified by a process called citrullination. Citrullination occurs in inflamed tissues and can trigger an immune response in some people, leading to rheumatoid arthritis. Anti-CCP is not only useful for diagnosing rheumatoid arthritis, but also for predicting its severity and progression.
Besides RF and anti-CCP, there are other biomarkers that can help to diagnose and monitor arthritis, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which are indicators of inflammation; angiotensinogen (AGT), serum amyloid A-4 protein (SAA4), vitamin D-binding protein (VDBP), and retinol-binding protein-4 (RBP4), which are proteins that have been found to be differentially expressed in the blood of people with rheumatoid arthritis; and antinuclear antibody (ANA), which is an antibody that can be detected in some autoimmune diseases, including rheumatoid arthritis.
If you or someone you know has symptoms of arthritis, such as joint pain, swelling, stiffness, or reduced mobility, we encourage you to consult your doctor and ask for a biomarker test. Early diagnosis and treatment can make a difference in preventing joint damage and improving quality of life.
GOLDSITE DIGANOSTICS INC. is a leading manufacturer of IVD products dedicated to the healthcare sector. With over 23 years of expertise in the IVD industry, Goldsite has established itself as a trusted partner since 1999. With a team of experts in the field of diagnostics technology and a passion for improving healthcare, we strive to bring cutting-edge products to market that meet the evolving needs of health providers and patients. Engaged in R&D, manufacturing, and marketing of clinical laboratory devices and reagents, Goldsite has a portfolio of products covering specific proteins, chemistry, chemiluminescence, and POCT platform, as well as associated reagents. All products live up to global standards with CE marking and have been exported to more than 80+ countries.
Our vision is to deliver state-of-art solutions that enhance patient care and improve health outcomes. We are dedicated to providing healthcare professionals with the tools they need to deliver accurate and reliable diagnoses, while also making medical diagnostics more accessible and affordable for all. We aim to make a positive impact on global health and well-being.
For more information, stay connected with us on our social media platforms to keep up-to-date with the latest industry news and trends, as well as insights and updates from our company. Follow us on Facebook, LinkedIn, YouTube, Twitter to be the first to know about our new products and services, events, and exciting R&D updates.
Link to our social media platform: